Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1991-9-26
pubmed:abstractText
We have defined structural features that are apparently important for the binding of four different, unrelated antigenic epitopes to the same major histocompatibility complex (MHC) class I molecule, H-2Kd. The four epitopes are recognized in the form of synthetic peptides by cytotoxic T lymphocytes of the appropriate specificity. By analysis of the relative potency of truncated peptides, we demonstrated that for each of the four epitopes, optimal antigenic activity was present in a peptide of 9 or 10 amino acid residues. A comparison of the relative competitor activity of the different-length peptides in a functional competition assay, as well as in a direct binding assay based on photoaffinity labeling of the Kd molecule, indicated that the enhanced potency of the peptides upon reduction in length was most likely due to a higher affinity of the shorter peptides for the Kd molecule. A remarkably simple motif that appears to be important for the specific binding of Kd-restricted peptides was identified by the analysis of peptides containing amino acid substitutions or deletions. The motif consists of two elements, a Tyr in the second position relative to the NH2 terminus and a hydrophobic residue with a large aliphatic side chain (Leu, Ile, or Val) at the COOH-terminal end of the optimal 9- or 10-mer peptides. We demonstrated that a simple peptide analogue (AYP6L) that incorporates the motif can effectively and specifically interact with the Kd molecule. Moreover, all of the additional Kd-restricted epitopes defined thus far in the literature contain the motif, and it may thus be useful for the prediction of new epitopes recognized by T cells in the context of this MHC class I molecule.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-1694221, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-1700303, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-1700304, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-1704034, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-1704348, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2295089, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2333291, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2358457, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2435001, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2442285, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2443855, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2449284, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2465495, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2466767, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2469442, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2477703, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2594067, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2639768, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2665439, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2809202, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2837512, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-2946957, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-3083654, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-3086429, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-3128632, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-3258651, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-3309677, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-3422468, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-3459185, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-3961484, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-4278108, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-6178607, http://linkedlifedata.com/resource/pubmed/commentcorrection/1714934-92183
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
174
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
603-12
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
H-2Kd-restricted antigenic peptides share a simple binding motif.
pubmed:affiliation
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't